Anixa Biosciences Inc
For the period ended Apr 30, 2024. Filed Jun 4, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 30, 2024 · Filed Jun 4, 2024
ANIX$3.16-0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
As of April 30, 2024, there were no Rule 10b5-1 plans in place for any of our directors or officers.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.